Johnson & JohnsonvsSBC Medical Group

JNJ and SBC stock compared: price, dividend, valuation and results, from SEC filings.

SBC

SBC Medical Group Holdings Incorporated

$6.18

Value $634M

-15.92%
SBC's page

Johnson & Johnson (JNJ) has a market value of $681B and SBC Medical Group (SBC) $634M. Over the last year, with dividends, JNJ moved +47.5% and SBC +86.7%. The P/E is 42.3 for JNJ and 12.2 for SBC. Dividend yield: JNJ 1.87%, SBC none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$681B

    SBC$634M

    JNJ is 1,074 times SBC

  • Revenue, 12 months

    JNJ$99.3B

    SBC$190M

    JNJ is 522 times SBC

  • Net income, 12 months

    JNJ$16.1B

    SBC$52M

    JNJ is 310 times SBC

  • Operating margin

    JNJ–

    SBC39.9%

  • ROIC

    JNJ12.4%

    SBC16.3%

    3.9 points apart

  • P/E

    JNJ42.3

    SBC12.2

    JNJ is 3.5 times SBC

  • Dividend yield

    JNJ1.9%

    SBC0.0%

    1.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+105.0%

SBC-42.0%

50100150200202420252026
Returns by period
PeriodJNJWith dividendsSBCWith dividends
1 year since November 14, 2025+47.5%Price +44.2%+86.7%Price +86.7%
3 years since November 16, 2023+105.0%+27.0% a yearPrice +88.2%-42.0%-16.6% a yearPrice -42.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonSBCSBC Medical Group

Valuation

JNJSBC
Valuation
Price$282.55$6.18
Market value$681B$634M
Enterprise value (EV)$708B$478M
P/E42.312.2
P/E, 5-year median21.911.6
P/B8.42.2
EV/EBIT39.96.3
Free cash flow yield3.0%15.8%

Results and growth

JNJSBC
Results and growth
Revenue, 12 months$99.3B$190M
Net income, 12 months$16.1B$52M
Free cash flow, 12 months$20.6B$100M
Earnings per share, 12 months$6.59$0.50
Revenue growth, year on year6.1%-15.5%
Revenue growth a year, past+2.7%over 5 years-5.3%over 2 years
EPS growth a year, past+14.9%over 5 years+9.1%over 2 years

Margins and returns on capital

JNJSBC
Margins and returns on capital
Gross margin67.6%72.2%
Operating margin–39.9%
Net margin16.2%27.3%
ROIC12.4%16.3%
ROE19.7%19.9%

Balance sheet

JNJSBC
Balance sheet
Cash$17.2B$199M
Total debt$44.7B$53M
Net debt / EBITDA1.1-2.0
Interest cover18.0×181.9×

Dividends and buybacks

JNJSBC
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%0.8%
Shareholder yield2.7%0.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or SBC

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or SBC Medical Group?

By market value, Johnson & Johnson ($681B) is about 1,074.1 times SBC Medical Group ($634M), at today's prices.

How did JNJ and SBC stock do over the last 3 years?

Since November 16, 2023, JNJ's price moved +88.2% and SBC's -42.0%. With dividends: JNJ +105.0% (+27.0% a year), SBC -42.0% (-16.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or SBC?

The dividend yield at today's price is 1.87% for Johnson & Johnson and none for SBC Medical Group. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and SBC?

At today's price, the P/E is 42.3 for JNJ and 12.2 for SBC. The median of the last five years was 21.9 and 11.6, which shows where each stands against its own past.

Which has the higher profit margins, Johnson & Johnson or SBC Medical Group?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 27.3% for SBC Medical Group, and the operating margin – and 39.9%. Revenue was $99.3B and $190M.

Which is the better investment, Johnson & Johnson or SBC Medical Group?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.